Drug Interactions Database

6278 interactions from BNF 85 - Check your medicines

Source: BNF 85

Severity: All 6278 Severe 944 Moderate 1418 Unknown 3916

filgotinib etanercept

increases risk of immunosuppression

Severe Theoretical

filgotinib golimumab

increases risk of immunosuppression

Severe Theoretical

filgotinib infliximab

increases risk of immunosuppression

Severe Theoretical

filgotinib leflunomide

increases risk of immunosuppression

Severe Theoretical

filgotinib monoclonalantibodies

increases risk of immunosuppression

Severe Theoretical

filgotinib rituximab

increases risk of immunosuppression

Severe Theoretical

filgotinib sarilumab

increases risk of immunosuppression

Severe Theoretical

filgotinib secukinumab

increases risk of immunosuppression

Severe Theoretical

filgotinib tacrolimus

increases risk of immunosuppression

Severe Theoretical

filgotinib teriflunomide

increases risk of immunosuppression

Severe Theoretical

filgotinib tocilizumab

increases risk of immunosuppression

Severe Theoretical

filgotinib tofacitinib

increases risk of immunosuppression

Severe Theoretical

fluconazole bosentan

increases exposure

Severe Study

fluconazole endothelinreceptorantagonists

increases exposure

Severe Study

flupentixol dopaminereceptoragonists

decreases effects

Severe Theoretical

fluvoxamine fedratinib

increases exposure

Severe Theoretical

fluvoxaminevery agomelatine

increases exposure

Severe Study

fluvoxaminevery melatonin

increases exposure

Severe Study

fluvoxaminevery tizanidine

increases exposure

Severe Study

folates fluorouracil

increases risk of toxicity

Severe Theoretical

fostemsavir grazoprevir

increases exposure

Severe Theoretical

gemfibrozil bexarotene

increases concentration

Severe Study

gemfibrozil meglitinides

increases exposure

Severe Study

gemfibrozil repaglinide

increases exposure

Severe Study

gemfibrozil retinoids

increases concentration

Severe Study

gemfibrozil selexipag

increases exposure

Severe Study

glecaprevirwithpibrentasvir dabigatran

increases exposure

Severe Study

glecaprevirwithpibrentasvir thrombininhibitors

increases exposure

Severe Study

glucosamine coumarins

increases anticoagulant effect

Severe Anecdotal

glucosamine warfarin

increases anticoagulant effect

Severe Anecdotal

grapefruit upadacitinib

increases exposure

Severe Theoretical

grapefruitjuice abemaciclib

increases exposure

Severe Theoretical

grapefruitjuice aliskiren

decreases exposure

Severe Study

grapefruitjuice amiodarone

increases exposure

Severe Study

grapefruitjuice antiarrhythmics

increases exposure

Severe Study

grapefruitjuice antihistamines,non-sedating

increases exposure

Severe Study

grapefruitjuice antimalarials

increases concentration

Severe Theoretical

grapefruitjuice antipsychotics,secondgeneration

increases exposure

Severe Theoretical

grapefruitjuice avapritinib

increases exposure

Severe Theoretical

grapefruitjuice bosutinib

increases exposure

Severe Theoretical

grapefruitjuice brigatinib

increases concentration

Severe Study

grapefruitjuice budesonide

increases exposure

Severe Study

grapefruitjuice buspirone

increases exposure

Severe Study

grapefruitjuice calciumchannelblockers

increases exposure

Severe Study

grapefruitjuice cariprazine

increases exposure

Severe Study

grapefruitjuice ceritinib

increases exposure

Severe Theoretical

grapefruitjuice cobimetinib

increases exposure

Severe Theoretical

grapefruitjuice crizotinib

increases exposure

Severe Theoretical

grapefruitjuice dasatinib

increases exposure

Severe Theoretical

grapefruitjuice dronedarone

increases exposure

Severe Study

Prev 1 ... 5 6 7 8 9 ... 126 Next

6278 interactions

Important: This database uses data from the British National Formulary (BNF 85). It is for informational purposes only and is not a substitute for professional medical advice.